Non‐pharmaceutical interventions vs placebo or no intervention
- Pharmacological and non‐pharmacological strategies for obese women with subfertility 2021 · Cochrane Headline outcomes onlyno estimate extracted1 study · 43 participantsVery low
The review found no eligible studies for this question.
It is very uncertain whether nifedipine changes pain relief (any) compared with placebo (very low certainty).
It is very uncertain whether nifedipine changes good or excellent pain relief compared with placebo (very low certainty).
The review found no eligible studies for this question.
It is very uncertain whether nifedipine changes total adverse effects compared with placebo (very low certainty).
It is very uncertain whether nifedipine changes bothersome adverse effects compared with placebo (very low certainty).
It is very uncertain whether nifedipine changes requirement for additional medication compared with placebo (very low certainty).
It is very uncertain whether hydroflotation agents changes pelvic pain compared with no hydroflotation agents (or placebo) (very low certainty).
Gel agents showed no clear difference in clinical pregnancy rate compared with no gel agents (or placebo) (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Hydroflotation agents showed no clear difference in live birth rate compared with no hydroflotation agents (or placebo) (low certainty).
Steroids (any route) may leads to lower live birth rate compared with no steroids (or placebo) (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Steroids (any route) showed no clear difference in clinical pregnancy rate compared with no steroids (or placebo) (low certainty).
The review found no eligible studies for this question.
Hydroflotation agents leads to lower incidence of adhesions at second‐look laparoscopy compared with no hydroflotation agents (or placebo) (high certainty).